Patterson Companies, Inc. (NASDAQ:PDCO – Get Free Report) was the recipient of a significant decline in short interest in the month of February. As of February 15th, there was short interest totalling 1,970,000 shares, a decline of 22.1% from the January 31st total of 2,530,000 shares. Based on an average daily volume of 1,430,000 shares, the short-interest ratio is currently 1.4 days. Currently, 2.5% of the company’s shares are short sold.
Patterson Companies Price Performance
NASDAQ:PDCO opened at $31.14 on Tuesday. Patterson Companies has a 12-month low of $19.45 and a 12-month high of $31.79. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of 18.21, a price-to-earnings-growth ratio of 2.71 and a beta of 0.90. The company’s 50-day moving average is $30.96 and its two-hundred day moving average is $25.51. The company has a current ratio of 1.37, a quick ratio of 0.76 and a debt-to-equity ratio of 0.34.
Patterson Companies (NASDAQ:PDCO – Get Free Report) last released its earnings results on Thursday, December 5th. The company reported $0.47 earnings per share for the quarter, missing the consensus estimate of $0.49 by ($0.02). The business had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.65 billion. Patterson Companies had a return on equity of 19.77% and a net margin of 2.37%. The business’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.50 earnings per share. Research analysts expect that Patterson Companies will post 2.25 EPS for the current year.
Analyst Ratings Changes
Get Our Latest Report on Patterson Companies
Insider Activity at Patterson Companies
In other Patterson Companies news, CEO Donald Zurbay sold 1,962 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $23.08, for a total transaction of $45,282.96. Following the sale, the chief executive officer now owns 222,736 shares of the company’s stock, valued at approximately $5,140,746.88. This trade represents a 0.87 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.90% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the business. BNP Paribas Financial Markets increased its position in shares of Patterson Companies by 31.5% in the third quarter. BNP Paribas Financial Markets now owns 33,257 shares of the company’s stock worth $726,000 after acquiring an additional 7,969 shares in the last quarter. Equity Investment Corp increased its holdings in Patterson Companies by 10.6% in the 3rd quarter. Equity Investment Corp now owns 1,739,669 shares of the company’s stock valued at $37,994,000 after purchasing an additional 166,899 shares in the last quarter. Goodman Financial Corp raised its position in Patterson Companies by 19.1% in the third quarter. Goodman Financial Corp now owns 543,282 shares of the company’s stock valued at $11,865,000 after purchasing an additional 86,972 shares during the period. Mork Capital Management LLC lifted its stake in shares of Patterson Companies by 142.9% during the third quarter. Mork Capital Management LLC now owns 84,980 shares of the company’s stock worth $1,856,000 after purchasing an additional 50,000 shares in the last quarter. Finally, Barclays PLC boosted its position in shares of Patterson Companies by 37.2% in the third quarter. Barclays PLC now owns 165,715 shares of the company’s stock worth $3,619,000 after buying an additional 44,906 shares during the period. Hedge funds and other institutional investors own 85.43% of the company’s stock.
About Patterson Companies
Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.
See Also
- Five stocks we like better than Patterson Companies
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Mediterranean Growth Monster: CAVA Keeps Surging—Buy the Dip?
- What Makes a Stock a Good Dividend Stock?
- Is the S&P 500 Ready to Rally? A $1.8M Bet on SPY Says Yes
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Consumer Spending Is Slowing—But These Stocks Will Still Thrive
Receive News & Ratings for Patterson Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patterson Companies and related companies with MarketBeat.com's FREE daily email newsletter.